These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9062415)

  • 21. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.
    Soubeyran I; Quénel N; Coindre JM; Bonichon F; Durand M; Wafflart J; Mauriac L
    Br J Cancer; 1996 Oct; 74(7):1120-5. PubMed ID: 8855985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
    Calzada L; Salazar EL; Pedron Nuevo N
    Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data.
    Townsend PA; Dublin E; Hart IR; Kao RH; Hanby AM; Cutress RI; Poulsom R; Ryder K; Barnes DM; Packham G
    J Pathol; 2002 May; 197(1):51-9. PubMed ID: 12081204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putative relationship between hormonal status and serum pyrrolidone carboxypeptidase activity in pre- and post- menopausal women with breast cancer.
    Carrera-González Mdel P; Ramírez-Expósito MJ; Dueñas B; Martínez-Ferrol J; Mayas MD; Martínez-Martos JM
    Breast; 2012 Dec; 21(6):751-4. PubMed ID: 22381154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
    Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
    Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: a randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy.
    Hojo T; Kinoshita T; Imoto S; Shimizu C; Isaka H; Ito H; Imi K; Wada N; Ando M; Fujiwara Y
    Breast; 2013 Jun; 22(3):263-7. PubMed ID: 23587451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers.
    Guarnieri A; Neri A; Correale PP; Lottini M; Testa M; Mariani F; Tucci E; Megha T; Cintorino M; Carli A
    Eur J Surg; 2001 Apr; 167(4):255-9. PubMed ID: 11354316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer.
    Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
    Gynecol Endocrinol; 2009 Mar; 25(3):183-7. PubMed ID: 19347708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time trends in breast cancer survival: experience in a single centre, 1975-89.
    Bradburn MJ; Altman DG; Smith P; Fentiman IS; Rubens RD
    Br J Cancer; 1998 Jun; 77(11):1944-9. PubMed ID: 9667672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer risk factors: a comparison between pre-menopausal and post-menopausal women.
    Butt Z; Haider SF; Arif S; Khan MR; Ashfaq U; Shahbaz U; Bukhari MH
    J Pak Med Assoc; 2012 Feb; 62(2):120-4. PubMed ID: 22755371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between estrogen receptor concentration in breast cancer tissue and bone mineral density.
    Sriussadaporn S; Srimuninnimit V; Ploybutr S; Tanlakit M; Chearskul S; Chakrapee-Sirisuk S; Nitiyanant W; Vannasaeng S; Sinlarat P; Vichayanrat A
    J Med Assoc Thai; 2002 Mar; 85(3):327-33. PubMed ID: 12117021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolic syndrome and breast cancer risk in post-menopausal women].
    Petrovanu C; Coman AE; Murariu GC; Petrovanu R
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):630-4. PubMed ID: 20201243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
    Pyrhönen S; Valavaara R; Modig H; Pawlicki M; Pienkowski T; Gundersen S; Bauer J; Westman G; Lundgren S; Blanco G; Mella O; Nilsson I; Hietanen T; Hindy I; Vuorinen J; Hajba A
    Br J Cancer; 1997; 76(2):270-7. PubMed ID: 9231932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.
    Bontenbal M; Foekens JA; Lamberts SW; de Jong FH; van Putten WL; Braun HJ; Burghouts JT; van der Linden GH; Klijn JG
    Br J Cancer; 1998; 77(1):115-22. PubMed ID: 9459155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lifetime exercise activity and breast cancer risk among post-menopausal women.
    Carpenter CL; Ross RK; Paganini-Hill A; Bernstein L
    Br J Cancer; 1999 Aug; 80(11):1852-8. PubMed ID: 10468309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.
    Kontos M; Allen DS; Agbaje OF; Hamed H; Fentiman IS
    Eur J Surg Oncol; 2011 Dec; 37(12):1051-8. PubMed ID: 21843919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.
    Avril A; Le Bouëdec G; Lorimier G; Classe JM; Tunon-de-Lara C; Giard S; MacGrogan G; Debled M; Mathoulin-Pélissier S; Mauriac L;
    Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis.
    Protani M; Coory M; Martin JH
    Breast Cancer Res Treat; 2010 Oct; 123(3):627-35. PubMed ID: 20571870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Food habits, socioeconomic status and body mass index among premenopausal and post-menopausal women in Mauritius.
    Bhurosy T; Jeewon R
    J Hum Nutr Diet; 2013 Jul; 26 Suppl 1():114-22. PubMed ID: 23600898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer.
    Bonin S; Brunetti D; Benedetti E; Gorji N; Stanta G
    Virchows Arch; 2006 May; 448(5):539-44. PubMed ID: 16440198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.